You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽生藥業(06600.HK)與順豐醫藥開啟戰略合作攜手打造生命健康領域F2C一站式供應鏈方案
格隆匯 04-23 06:20

格隆匯 4 月 23日丨賽生藥業(06600.HK)發佈公吿,公司欣然宣佈與上海順豐醫藥供應鏈控股有限公司(順豐醫藥,順豐控股(002352.SZ)的全資子公司)正式開啟戰略合作,順豐醫藥成為公司認證的供應鏈服務商,雙方將攜手打造F端生命健康企業至C端患者用户的一站式供應鏈方案,進一步深化和發展公司的Go-To-Patient(“GTP”)的創新商業模式,為患者提供專業、安全和可靠的全流程端到端服務,共建中國生命健康領域F2C供應鏈的更高標準。

依託順豐醫藥全鏈信息可視化的創新業務模式,深化拓展公司的GTP平台

公司創新的GTP模式將處方藥的銷售範圍從醫院擴展到藥房,提高了藥品對患者的可及性,也實現了銷售渠道多元化及最大限度擴大患者的覆蓋範圍。患者可在線下問診並在免e在線門户網站上註冊後上傳處方,實現線上訂購及配送或者線下DTP藥房購買及取藥。

公司認同順豐醫藥在生命健康領域具有供應鏈適配和響應能力,在人力、產能及作業的數字化實力,和端到端可視化的能力。此次服務商認證與戰略合作標誌着生命健康領域F2C供應鏈行業標準體系的建立,將進一步深化和發展公司的GTP模式,拓寬對患者人羣的覆蓋,提升對患者服務的效率和產品質量的保證。雙方通過本次合作將實現:端到端直達到C的物流,倉庫就近發貨,提升供應鏈效率;全程數據服務,獲得最真實的流向數據,合理管理存量客户和增量客户;對定向的商流渠道進行管理支持,對違反渠道管理要求的商流可以準確真實的發現;全程專業温濕度保障和信息追溯,讓患者可以獲得安心的藥品服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account